Position in NVO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$757,452
-$230,271,459 QoQ
Shares Held
15,800
-99.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#591
of 1,348 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Derivatives in NVO
reported options exposure · as of Jun 30, 2026CallValue
$3,183,216
CallShares
66,400
PutValue
$3,010,632
PutShares
62,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $1,287,408,532 across 15 Drug Manufacturers - General names. NVO ranks #15 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
10,085,383 | $581,119,768 | |
| 2 | AMGN |
Amgen Inc
|
1,128,681 | $408,717,963 | |
| 3 | LLY |
ELI LILLY & Co
|
81,240 | $97,441,701 | |
| 4 | AZN |
Astrazeneca PLC
|
329,087 | $62,401,476 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
409,174 | $51,695,043 | |
| 6 | ABBV |
AbbVie Inc.
|
198,249 | $49,887,378 | |
| 7 | JNJ |
Johnson & Johnson
|
34,909 | $8,865,838 | |
| 8 | PFE |
Pfizer Inc
|
330,300 | $7,953,624 |
All Filings in NVO
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,010,632 | 62,800 | Put | Sole | 2026-08-14 | |
| 2026-06-30 | $3,183,216 | 66,400 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $757,452 | 15,800 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $856,275 | 23,300 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $231,028,911 | 6,286,501 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $4,465,125 | 121,500 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $17,461,558 | 343,191 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $6,716,160 | 132,000 | Put | Sole | 2026-02-17 | |
| 2025-12-31 | $6,716,160 | 132,000 | Call | Sole | 2026-02-17 | |
| 2025-09-30 | $93,862,777 | 1,691,526 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $153,013,889 | 2,216,950 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $218,592,189 | 3,147,929 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $158,657,266 | 1,844,423 | Shares | Sole | 2025-02-14 | |
| 2023-12-31 | $2,234,520 | 21,600 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,967,032 | 21,630 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $53,673,670 | 331,667 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,826,079 | 30,326 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,218,060 | 9,000 | Shares | Sole | 2023-02-14 | |
| 2022-06-30 | $14,281,648 | 128,167 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $12,080,352 | 108,783 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $37,583,280 | 335,565 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $74,417,254 | 775,099 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $38,527,917 | 459,925 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $30,341,629 | 450,039 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $38,558,247 | 552,015 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $33,324,317 | 479,970 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $44,755,252 | 683,495 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $18,571,338 | 308,494 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||